{"database": "lobbying", "table": "lobbying_activities", "rows": [[790574, "2a96042c-8e38-46f6-a3bb-a541357d4da7", "Q2", "POLICY DIRECTIONS INC.", 31747, "QRXPHARMA LIMITED", 2009, "second_quarter", "MED", "Collaboration in licensing of PTSD/acute depression use of scopolamine;\nNIH/Office of Technology Transfer", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH)", 10000, null, 0, 0, "2009-07-15T15:41:22-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["790574"], "units": {}, "query_ms": 0.3528819652274251, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}